Privigen®
Understanding Privigen®
Privigen® is an intravenous immune globulin (IVIG) therapy used to boost the immune system and treat various immune-related conditions. Made from purified human plasma, Privigen® contains immunoglobulin G (IgG) antibodies that help protect against infections and regulate immune responses. This therapy is used to support immune function in patients with primary immunodeficiencies (PI) and autoimmune conditions affecting the immune system.
How Privigen® Works:
- Provides IgG antibodies to support the immune system.
- Helps fight infections in individuals with weakened immune defenses.
- Modulates the immune response in autoimmune and inflammatory conditions.
FDA Approval:
- Privigen®: Approved in 2007
For more information, please visit the Privigen® patient website and speak with your healthcare provider to determine if Privigen® is the right treatment option for you.
Referral Form: |
WHAT IT TREATS: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Chronic Spontaneous Urticaria (CSU)Common Variable Immunodeficiency (CVID)Guillain-Barre Syndrome (GBS)Immune Thrombocytopenic Purpura (ITP)Kawasaki Disease (KD)Kidney TransplantMyasthenia Gravis (MG)Primary Immunodeficiency (PID)Severe Combined Immunodeficiencies (SCID)Wiskott-Aldrich Syndrome (WAS)X-linked Agammaglobulinemia (XLA) |
MANUFACTURER: CSL Behring |
CLASS: Intravenous Immune Globulin (IVIG) Therapy |
|
PRESCRIBED BY:
|
|
HOW ADMINISTERED: IV infusion |
|
FREQUENCY: For PI: Typically every 3 to 4 weeks |
Length of infusion: Varies from one hour to several hours depending on the dose |
FOR MORE INFORMATION: |
